Literature DB >> 12016128

T cell receptor delta repertoire in inflamed and noninflamed colon of patients with IBD analyzed by CDR3 spectratyping.

Wolfgang Holtmeier1, Andreas Hennemann, Ekkehard May, Rainer Duchmann, Wolfgang F Caspary.   

Abstract

Gamma/delta T cells might play an important role in autoimmune conditions like inflammatory bowel disease (IBD). In the present study, we characterized the T cell receptor (TCR)-delta repertoire by complementarity determining region 3 (CDR3) spectratyping in the inflamed and noninflamed mucosa and in the peripheral blood of subjects with Crohn's disease and ulcerative colitis. In contrast to previously published data about alpha/beta T cells, we rarely found oligoclonal expansions of gamma/delta T cells specific only for the inflamed mucosa. The same dominant gamma/delta T cell expansions were also present in the noninflamed colon. Furthermore, the peripheral gamma/delta TCR repertoire was oligoclonal but clearly distinct from that in the inflamed intestine. Thus our results do not support a role for antigen-specific gamma/delta T cells in IBD, and dominant gamma/delta T cells of the peripheral blood are not likely to be derived from the inflamed gut. However, in several patients, the TCR-delta-repertoire was highly diversified, whereas in others we observed a loss of dominant gamma/delta T cell clones when inflamed and noninflamed mucosa were compared. In conclusion, those changes indicate that gamma/delta T cells might play an important role in a subset of patients with IBD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12016128     DOI: 10.1152/ajpgi.00224.2001

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  9 in total

1.  Antigen receptor V-segment usage in mucosal T cells.

Authors:  A G Edwards; A R Weale; A J Denny; K J Edwards; C R Helps; P A Lear; M Bailey
Journal:  Immunology       Date:  2007-09-26       Impact factor: 7.397

2.  Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity.

Authors:  Charles T Spencer; Getahun Abate; Azra Blazevic; Daniel F Hoft
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  Decreased colorectal cancer and adenoma risk in patients with microscopic colitis.

Authors:  Eugene F Yen; Bhupesh Pokhrel; Laura K Bianchi; Hemant K Roy; Hongyan Du; Amir Patel; Curtis R Hall; Benjamin L Witt
Journal:  Dig Dis Sci       Date:  2011-08-17       Impact factor: 3.199

4.  Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.

Authors:  E R Mann; N E McCarthy; S T C Peake; A N Milestone; H O Al-Hassi; D Bernardo; C T Tee; J Landy; M C Pitcher; S A Cochrane; A L Hart; A J Stagg; S C Knight
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

5.  Low Prevalence of Colon Polyps in Chronic Inflammatory Conditions of the Colon.

Authors:  Amnon Sonnenberg; Robert M Genta
Journal:  Am J Gastroenterol       Date:  2015-04-28       Impact factor: 10.864

6.  Activation and Costimulation of Intestinal T Cells: Independent and Collaborative Involvement of CD43, OX40, and Ly-6C.

Authors:  Dina Montufar-Solis; John R Klein
Journal:  Curr Immunol Rev       Date:  2005-01

7.  Infliximab induces clonal expansion of γδ-T cells in Crohn's disease: a predictor of lymphoma risk?

Authors:  Jens Kelsen; Anders Dige; Heinrich Schwindt; Francesco D'Amore; Finn S Pedersen; Jørgen Agnholt; Lisbet A Christensen; Jens F Dahlerup; Christian L Hvas
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

8.  T-cell repertoires in refractory coeliac disease.

Authors:  Julia Ritter; Karin Zimmermann; Korinna Jöhrens; Stefanie Mende; Anke Seegebarth; Britta Siegmund; Steffen Hennig; Kremena Todorova; Andreas Rosenwald; Severin Daum; Michael Hummel; Michael Schumann
Journal:  Gut       Date:  2017-02-10       Impact factor: 23.059

9.  Reduced diversity of intestinal T-cell receptor repertoire in patients with Crohn's disease.

Authors:  Sung Noh Hong; Joo-Young Park; So-Yun Yang; Chansu Lee; Young-Ho Kim; Je-Gun Joung
Journal:  Front Cell Infect Microbiol       Date:  2022-08-10       Impact factor: 6.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.